Cannabis Law Report

FEBRUARY 20, 2020

by Rachel Garland, Green-Flower Media. Pharmacopeia as a treatment for several conditions including: tetanus, gout, tonsillitis, alcoholism, menstrual cramps, cholera, arthritis, and many others. 4) Tinctures give you different cannabinoid options. Or CBD tinctures, and even tinctures with the acidic cannabinoids THCA and CBDA.

Tincture 59

Tincture Media Cannabinoids Topical 59

Cannabis Law Report

AUGUST 17, 2021

RLS103 is being developed for the treatment of performance anxiety in patients with social anxiety disorder (SAD), and acute panic in patients with panic disorder. Currently, there are no FDA approved treatment options available for these patients.”. Email: media@receptorlife.com. David Sheon.

CBD 98

CBD Research and Development Pharmaceutical Therapy 98

MMJ Recs

FEBRUARY 29, 2024

The landscape of medical marijuana has evolved, offering patients alternative avenues for accessing therapeutic cannabis. Florida allows qualified patients to access medical marijuana, but home cultivation is generally not permitted. Home cultivation is not explicitly allowed under the current regulations.

Cultivation 52

Cultivation Marijuana Environment Patients 52

Veriheal

AUGUST 15, 2023

Halilovic told the media that, “Once The fighting ends, the new fight will start. The National Center for PTSD says, “People with PTSD have greater availability of cannabinoid type 1 (CB1) receptors as compared to trauma-exposed or healthy controls (18,19). To rebuild cities. And to heal. And to heal is the most difficult.”

Legalization 97

Legalization Chronic Pain Media Conditions 97

Greencamp

NOVEMBER 21, 2018

I wanted to find out if there is some evidence of successful application of cannabis for eating disorders, so I decided to start off with figuring out what eating disorders actually are and which studies explain the complex relationship between eating and cannabinoids. What are eating disorders?

Treatment 76

Treatment Research and Development Cannabinoids Conditions 76

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. Another influential factor is the growing emphasis on individual autonomy and patient choice in healthcare.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

DECEMBER 22, 2021

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. million of secured convertible debentures in Hyasynth (the “Debentures”).

Cannabinoids 52

Cannabinoids Research and Development Events Pharmaceutical 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

SpeedWeed

AUGUST 3, 2021

so it may enhance the effects of chemotherapy treatment in stopping these tumours growing, allowing patients to live longer. The study will include the recruitment of 232 patients in early 2022 chosen from approximately 15 different hospitals and cancer centers in the United Kingdom. Sativex as a Potential Savior.

Treatment 71

Treatment Patients Medicine Media 71

MMJ Recs

JANUARY 22, 2024

Among these, medical marijuana edibles have emerged as a discreet and palatable option for patients seeking the therapeutic benefits of cannabis without the traditional methods of smoking or vaporizing. This delayed onset is due to the digestive process, as cannabinoids are metabolized in the liver before entering the bloodstream.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. What marijuana products are allowed in Japan?

Law 137

Law Legalization Clinical Trials CBD 137

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

MMJ Recs

JANUARY 13, 2024

Patients seeking relief from various ailments are increasingly turning to specific cannabis strains renowned for their therapeutic properties. The realm of MMJ is expanding rapidly, with various types becoming the most popular MMJ strains due to their unique combinations of cannabinoids and terpenes.

Strains 52

Strains Chronic Pain Indica Sativa 52

Veriheal

JULY 2, 2020

However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The original bill as drafted would have only opened the door to patients that had suffered a traumatic brain injury or a concussion.

Banking 52

Banking Programs Therapy Conditions 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”.

DEA 66

DEA Clinical Trials THC Research and Development 66

CannaMD

MAY 19, 2020

As the study authors acknowledge: Cannabis sativa, especially one high in the anti-inflammatory cannabinoid cannabidiol (CBD), has been proposed to modulate gene expression and inflammation and is under investigation for several potential therapeutic applications against cancer and various inflammatory diseases. Why Study Marijuana?

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

CannaMD

AUGUST 19, 2020

While COVID-19 can be deadly, the World Health Organization (WHO) stresses that most patients experience mild cases and/or survive: Most people who get COVID-19 have mild or moderate symptoms and can recover thanks to supportive care. Marijuana cannabinoid, CBD. ” And their alternative strategy of choice?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Alchimia

MARCH 16, 2016

Once the disease starts affecting the person, life expectancy greatly depends on patients (from 3 to 20 years), with an average of 8,5 years. Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Cannabis patient. Source: Spanish Society of Neurology ).

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

FEBRUARY 11, 2020

The hunger for knowledge and cannabis education exceeds the willingness of physicians to prescribe cannabis to patients according to a Shoppers Drug Mart survey. Of the zoomer cannabis consumers in Canada, close to half report using it for medical treatment, indicating an equal opportunity for recreational use among this cohort.

Education 59

Education Treatment Media Recreational 59

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. Questions included any changes in personal levels of opioid use when marijuana was also used, and the reasons why patients were substituting marijuana for prescription pain medications.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

OCTOBER 15, 2021

DNA variations or polymorphisms) in patients with African ancestry. The KGA is a proprietary computational platform built in-house at Goldfinch Bio to identify genetic and environmental causes of kidney diseases in patient subsets and the associated biological targets for therapeutic intervention. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

TheAnswerPage

SEPTEMBER 9, 2019

Is it common for HIV/AIDS patients to use cannabinoids for medicinal purposes? There are decades-worth of anecdotal reports from people living with HIV/AIDS attesting to cannabinoids’ beneficial effects on mitigating the symptoms of the disease, common co-morbidities, and side effects of treatment, including cachexia, pain, and nausea.

Epilepsy 40

Epilepsy Cannabinoids Media Education 40

The Cannigma

JULY 1, 2022

These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? The cannabis research problem. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. Media Releases. Track Inquiry.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

JANUARY 24, 2022

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Edwin (Ed) Tucker, M.D., CAMBRIDGE, Mass.–(BUSINESS as Chief Medical Officer (CMO), effective immediately. Dr. Tucker. “I

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

DECEMBER 14, 2021

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available for patients throughout the UK when prescribed by a specialist consultant. Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.

Extraction 52

Extraction Patients Medicine Tincture 52

Veriheal

OCTOBER 1, 2020

Amphetamines, barbiturates, cannabis, codeine, ketamine, methylphenidate (Ritalin), synthetic cannabinoids, synthetic cathinones (for example mephedrone, methoxetamine). In 2018, the government was confronted by a media storm that has called for them to act. As a result, the UK proposed medicinal cannabis regulations in 2018. .

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

TheAnswerPage

SEPTEMBER 18, 2019

Nabiximols (a cannabinoid medicine containing THC and CBD) is approved in Europe for the treatment of neuropathic pain, spasticity and bladder dysfunction in patients suffering from multiple sclerosis. Press/Media. Team Training. Answer of the Day. Today’s Answer of the Day. Leah Roach. September 19, 2019.

Epilepsy 40

Epilepsy Media Education Treatment 40

Cannabis Law Report

OCTOBER 14, 2021

patients must register at Opticann.ca Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ZoomerMedia’s powerful suite of media channels support C.A.R.P.’s This exciting new partnership with C.A.R.P.,

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: Agence France Presse). Source: FAC ).

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

The Cannigma

JUNE 24, 2021

The constant distractions, notifications, and social media outrages of the day can also boost your anxiety and stress, and make it much harder to just live in the moment. Nausea and vomiting — cannabis has long been seen as a potential supportive treatment option for cancer patients undergoing chemotherapy.

CBD 75

CBD Microdosing Edibles Sleep 75